nevus: Definition, Uses, and Clinical Overview

nevus Introduction (What it is)

A nevus is a benign (non-cancerous) growth made up of pigment-producing cells.
It is often called a “mole” on the skin, but it can also occur in and around the eye.
In eye care, nevus most commonly describes a pigmented spot in the conjunctiva, iris, or choroid.
Clinicians use the term to document findings and guide monitoring for change over time.

Why nevus used (Purpose / benefits)

In ophthalmology and optometry, nevus is primarily a diagnostic term rather than a treatment. Naming a lesion a nevus helps clinicians communicate what they see, record its features, and decide how closely it should be followed.

Key purposes and benefits include:

• Clarifying what the lesion most likely represents. Many pigmented eye findings are harmless, but some require additional evaluation to rule out malignancy (cancer) or other disease.
• Establishing a baseline for monitoring. A documented nevus can be photographed and measured so future changes in size, shape, elevation, or associated fluid can be recognized.
• Risk awareness and early detection. Most ocular nevi remain stable, but some can resemble or (rarely) transform into malignant melanoma. Careful classification and follow-up aim to detect suspicious change early.
• Supporting symptom evaluation. While many nevi cause no symptoms, a lesion may be discovered during evaluation of blurred vision, flashes/floaters, irritation, or a visible spot on the eye.
• Guiding referrals and imaging. The term can trigger appropriate use of imaging (for example, ocular ultrasound or optical coherence tomography) or referral to an ocular oncologist when features are atypical.

Indications (When ophthalmologists or optometrists use it)

Clinicians may use the term nevus in situations such as:

• A pigmented spot on the white of the eye (conjunctiva) noted by the patient or seen on routine exam
• A pigmented lesion on the iris (the colored part of the eye) seen at the slit lamp
• A choroidal pigmented lesion detected on dilated retinal examination
• A new or changing pigmented lesion found during screening for diabetic eye disease, glaucoma, or cataract
• Documentation of an incidental finding before or after eye surgery (for example, cataract surgery), to establish a baseline
• Follow-up of a previously documented lesion to assess stability vs change
• Evaluation of pigmented lesions in patients with a history of skin melanoma or significant sun-related skin findings (context varies by clinician and case)

Contraindications / when it’s NOT ideal

Because nevus is a descriptive diagnosis, “contraindications” usually mean situations where it may not be appropriate to label a lesion as a nevus without further work-up or where another diagnosis is more likely.

Situations where a different approach may be better include:

• Lesions with suspicious or rapidly changing features, where melanoma or another tumor must be considered
• Pigmented lesions with atypical vascularity, ulceration, bleeding, or marked irregularity, particularly on the conjunctiva
• Any lesion associated with new vision loss, new visual field changes, or persistent symptoms that suggest more than an incidental finding (evaluation pathways vary by clinician and case)
• Diffuse pigmentation patterns that may fit melanosis rather than a discrete nevus
• Lesions in which inflammation, hemorrhage, or scarring makes appearance unreliable, requiring imaging or specialist assessment
• Cases where the lesion’s appearance is unclear due to media opacity (for example, dense cataract), requiring deferred classification until adequate visualization is possible

How it works (Mechanism / physiology)

A nevus forms when melanocytes (cells that produce melanin pigment) cluster within a tissue. Melanin is the pigment that contributes to normal coloration of the skin, iris, and other tissues. In the eye, nevi are most often discussed in relation to three main locations:

• Conjunctiva: the clear membrane over the white of the eye and inner eyelids
• Iris: the colored diaphragm that controls pupil size
• Choroid: a vascular, pigmented layer beneath the retina that supports retinal function

At a high level, an ocular nevus is a localized collection of pigment-containing cells that appears as a spot or patch. Many are flat; some have mild elevation. The lesion itself does not “work” like a medication or device, so classic concepts like onset of action and duration do not apply.

Instead, clinically relevant properties include:

• Stability vs change over time. Many nevi remain stable for years. Some may slowly change in appearance, and a minority may develop features that raise concern for malignancy.
• Potential impact on surrounding tissues. A choroidal nevus may be associated with secondary findings such as overlying retinal changes or fluid, which can affect vision depending on location.
• Reversibility. A nevus generally does not “resolve” in the way an infection might. Management is typically based on documentation and monitoring, or treatment if a different diagnosis is established.

nevus Procedure overview (How it’s applied)

nevus is not a procedure. It is a clinical diagnosis and documentation term used during an eye exam. A typical workflow for evaluating a suspected ocular nevus is:

1. Evaluation / exam
   – History: onset, perceived growth, irritation, vision changes, prior eye conditions
   – External exam and slit-lamp exam for conjunctival and iris lesions
   – Dilated fundus exam for choroidal lesions

2. Preparation
   – Pupil dilation when viewing the choroid/retina is needed
   – Baseline photographs may be planned for comparison over time

3. Intervention / testing (assessment tools)
   – Clinical photography (external or fundus photos) to document size and appearance
   – Optical coherence tomography (OCT) to assess retinal layers and possible fluid (commonly for choroidal lesions)
   – Ultrasound when lesion thickness/elevation needs assessment (often in specialist settings)
   – Additional tests may be selected depending on lesion location and features (varies by clinician and case)

4. Immediate checks
   – Review for features that suggest a benign nevus versus a lesion requiring urgent evaluation
   – Documentation of size, location, borders, color, elevation, and associated findings

5. Follow-up
   – Follow-up intervals are chosen based on risk features, location, and imaging findings (varies by clinician and case)
   – Referral to ocular oncology or another specialist may be recommended when features are atypical

Types / variations

Ocular and periocular nevi are commonly described by location, appearance, and clinical behavior.

Common location-based types include:

• Conjunctival nevus
  Typically seen on the bulbar conjunctiva (the visible white of the eye). It may appear as a brown spot and can sometimes contain small clear cysts on slit-lamp exam. Some are noticed in childhood or young adulthood, though discovery can occur at any age.

• Iris nevus
  A pigmented spot or localized thickening on the iris. It may be subtle and only visible under magnification. Iris lesions are assessed for shape, vascularity, involvement of the pupil margin, and any secondary effects on eye structures.

• Choroidal nevus
  A pigmented lesion beneath the retina, seen on dilated exam. It can be gray-brown and flat or minimally elevated. Because it sits under the retina, clinicians often use imaging to look for associated retinal changes.

Other clinically used descriptors and variations:

• Amelanotic nevus
  A lesion with little visible pigment. These can be more challenging to recognize and may require imaging and careful documentation.

• Atypical nevus / indeterminate melanocytic lesion
  Terms sometimes used when a lesion has some features that do not fit a classic benign appearance but does not meet criteria for melanoma. Terminology and thresholds vary by clinician and case.

• Nevus vs freckle vs melanosis (terminology differences)
  Clinicians may distinguish discrete nevi from more diffuse pigmentation (melanosis) or small, flat pigmented areas sometimes referred to as freckles. The exact labeling depends on exam findings and clinical conventions.

Pros and cons

Pros:

• Provides a clear clinical label for a common pigmented finding
• Encourages baseline documentation (measurements and photos) for future comparison
• Supports risk-based monitoring when lesions have uncertain behavior
• Helps standardize communication between clinicians, students, and specialists
• Can reduce confusion by distinguishing benign-appearing lesions from conditions that need urgent evaluation
• Integrates well with imaging tools (photography, OCT, ultrasound) for objective follow-up

Cons:

• The term can be misunderstood by patients as automatically meaning “cancer” or “harmless,” when neither is universally true
• Some lesions are difficult to classify on a single visit, especially if visualization is limited
• There can be overlap in appearance between benign nevi and early melanoma, requiring careful judgment
• Documentation and monitoring may create ongoing follow-up needs, which can be burdensome for some patients
• Terminology and thresholds for “atypical” can vary, complicating comparisons between clinics
• Imaging results may be interpreted differently depending on equipment, image quality, and clinician experience (varies by material and manufacturer; and by clinician and case)

Aftercare & longevity

Because nevus is usually an observed finding rather than a treated condition, “aftercare” typically means ongoing observation and documentation. Longevity refers to how the lesion behaves over time and how reliable monitoring is.

Factors that can affect outcomes and monitoring quality include:

• Lesion location. For example, choroidal lesions near the macula (central retina) may be monitored more closely because small associated changes can affect central vision.
• Baseline documentation quality. Clear photographs and consistent measurement methods make future comparisons more meaningful.
• Follow-up consistency. Stable follow-up supports detection of gradual change; exact schedules vary by clinician and case.
• Ocular surface health. For conjunctival lesions, irritation, dryness, or inflammation can make the surface harder to evaluate consistently.
• Coexisting eye disease. Conditions such as cataract, corneal scarring, or vitreous haze can limit visualization of internal lesions.
• Patient-specific risk context. Personal history (for example, prior melanoma) may influence how clinicians frame monitoring and referrals (varies by clinician and case).

In many cases, nevi remain present long-term and are monitored for stability rather than “cured.”

Alternatives / comparisons

Since nevus is a diagnosis, “alternatives” usually refer to other diagnostic labels or management pathways depending on what the lesion represents.

Common comparisons include:

• Observation/monitoring vs biopsy/excision (mainly for external lesions)
  Some conjunctival lesions are monitored with serial photos, while others may be removed for diagnostic certainty if features are atypical. The decision depends on appearance, change over time, and clinician judgment (varies by clinician and case).

• Routine documentation vs specialist referral (ocular oncology)
  Many nevi can be documented in general eye care settings. Lesions with suspicious features may be referred for advanced imaging, longitudinal comparison, and specialized evaluation.

• Nevus vs melanoma
  A nevus is generally benign, while melanoma is malignant. The clinical challenge is that early melanoma can sometimes resemble a nevus, which is why imaging and follow-up patterns matter.

• Nevus vs melanosis
  Melanosis often implies a more diffuse pigmentation pattern rather than a discrete lump or spot. Management and risk considerations differ by subtype and location.

• Imaging options (photography vs OCT vs ultrasound)
  Photography documents appearance and size. OCT evaluates retinal layers and fluid when lesions are under the retina. Ultrasound can help assess thickness and internal characteristics in certain settings. Choice of modality varies by clinician and case.

nevus Common questions (FAQ)

Q: Is a nevus in the eye the same as a skin mole?
A nevus is conceptually similar: it is a cluster of pigment-producing cells. The key difference is location—ocular nevi can occur on the conjunctiva, iris, or beneath the retina (choroid). Because eye tissues are specialized and vision is involved, clinicians often document ocular nevi with imaging.

Q: Does a nevus mean I have eye cancer?
No. A nevus is typically benign. The reason it may receive careful attention is that some lesions can resemble melanoma or develop concerning features over time, so clinicians may recommend monitoring based on risk factors (varies by clinician and case).

Q: Will an ocular nevus affect my vision?
Many nevi cause no symptoms and are found incidentally. Vision effects depend mainly on location and whether there are secondary changes in nearby tissues (for example, retinal changes near central vision). Symptom patterns vary by lesion type and individual case.

Q: Is evaluation or imaging for nevus painful?
Most evaluation is done with standard eye exam tools and is not painful. Dilation drops may cause temporary light sensitivity and blur. Imaging such as photography or OCT is generally non-contact and brief; ultrasound methods differ by clinic and technique.

Q: How long does a nevus last?
A nevus is often long-lasting and may remain stable for years. Some lesions can change slowly, and clinicians focus on whether changes are expected/benign or concerning. “Duration” is better thought of as long-term behavior rather than a treatment effect.

Q: What does follow-up usually involve?
Follow-up typically involves comparing the lesion to prior notes and photos and repeating selected imaging when helpful. The interval depends on features such as size, location, and whether change is suspected. Specific schedules vary by clinician and case.

Q: Can I drive after an appointment for a nevus check?
If your pupils are dilated, you may have temporary blur and light sensitivity that can affect driving. Clinics often advise planning for this possibility, especially for longer drives or bright daytime conditions. Whether driving feels safe can vary between individuals.

Q: Does screen time make a nevus worse?
Screen use is not generally considered a direct cause of nevus growth. However, heavy screen time can worsen dry eye symptoms, which may make the eyes feel irritated and can complicate comfort during exams for surface lesions. Any relationship to lesion change is not established in typical clinical teaching.

Q: How much does evaluation or monitoring cost?
Costs vary widely based on location, insurance coverage, imaging needs, and whether a specialist is involved. A routine exam with basic documentation may differ in cost from visits requiring multiple imaging tests. Exact pricing varies by clinic and case.

Q: If a nevus changes, does it always need treatment?
Not always. Some changes may be minor or attributable to improved visualization or better imaging, while other changes may prompt additional testing or referral. Management decisions depend on the pattern of change and associated findings (varies by clinician and case).